TH
THISX
ETF
THISX
·
UNKNOWN
·
131 holdings
About THISX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- $80.72
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 65.6%
- HHI Score
- 336.70
- Top Sector
- Healthcare (79.563616%)
Moderate (20.9%)
↗ Recovering
Positive 1W (+1.88%) after negative 1M (-0.23%) — trend may be reversing
47.76%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 47.76% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Weighted by position size
Weighted avg. of top holdings
▼ -0.90%
ISRG
Intuitive Surgical Inc
UNH
UnitedHealth Group Inc
VRTX
Vertex Pharmaceuticals Inc
BSX
Boston Scientific Corp
TMO
Thermo Fisher Scientific Inc
ALNY
Alnylam Pharmaceuticals Inc
All Holdings (131)
Top 10: 47.76% of fund
| # |
Ticker |
Name |
Weight |
Shares |
Market Value |
| 1 |
LLY
|
Eli Lilly & Co |
11.93% |
1.73 M |
1.35 B |
| 2 |
ISRG
|
Intuitive Surgical Inc |
5.81% |
1.21 M |
657.08 M |
| 3 |
UNH
|
UnitedHealth Group Inc |
5.08% |
1.84 M |
574.68 M |
| 4 |
SYK
|
Stryker Corp |
4.98% |
1.42 M |
563.40 M |
| 5 |
VRTX
|
Vertex Pharmaceuticals Inc |
3.84% |
973,911 |
433.59 M |
| 6 |
BSX
|
Boston Scientific Corp |
3.69% |
3.88 M |
416.71 M |
| 7 |
ARGX
|
Argenx SE |
3.33% |
683,183 |
376.58 M |
| 8 |
DHR
|
Danaher Corp |
3.10% |
1.77 M |
350.11 M |
| 9 |
TMO
|
Thermo Fisher Scientific Inc |
3.07% |
854,687 |
346.54 M |
| 10 |
ALNY
|
Alnylam Pharmaceuticals Inc |
2.93% |
1.02 M |
331.16 M |
| 11 |
GILD
|
Gilead Sciences Inc |
2.41% |
2.45 M |
272.18 M |
| 12 |
INSM
|
Insmed Inc |
2.15% |
2.41 M |
242.60 M |
| 13 |
CI
|
Cigna Group/The |
2.11% |
720,172 |
238.07 M |
| 14 |
ELV
|
Elevance Health Inc |
1.93% |
561,120 |
218.25 M |
| 15 |
ABBV
|
AbbVie Inc |
1.75% |
1.07 M |
198.25 M |
| 16 |
PEN
|
Penumbra Inc |
1.45% |
639,140 |
164.02 M |
| 17 |
BeOne Medicines Ltd
|
BeOne Medicines Ltd |
1.41% |
8.21 M |
159.81 M |
| 18 |
AstraZeneca PLC
|
AstraZeneca PLC |
1.19% |
1.93 M |
134.56 M |
| 19 |
Verona Pharma PLC
|
Verona Pharma PLC |
1.14% |
1.36 M |
128.35 M |
| 20 |
Chugai Pharmaceutica
|
Chugai Pharmaceutical Co Ltd |
1.07% |
2.32 M |
121.39 M |
| 21 |
ASND
|
Ascendis Pharma A/S |
1.06% |
693,353 |
119.67 M |
| 22 |
REGN
|
Regeneron Pharmaceuticals Inc |
1.05% |
226,254 |
118.78 M |
| 23 |
THC
|
Tenet Healthcare Corp |
0.95% |
610,511 |
107.45 M |
| 24 |
NTRA
|
Natera Inc |
0.86% |
573,317 |
96.86 M |
| 25 |
Cencora Inc
|
Cencora Inc |
0.78% |
292,915 |
87.83 M |
| 26 |
HCA
|
HCA Healthcare Inc |
0.76% |
224,900 |
86.16 M |
| 27 |
NBIX
|
Neurocrine Biosciences Inc |
0.69% |
621,659 |
78.14 M |
| 28 |
DGX
|
Quest Diagnostics Inc |
0.65% |
406,310 |
72.99 M |
| 29 |
MOH
|
Molina Healthcare Inc |
0.65% |
244,877 |
72.95 M |
| 30 |
SRRK
|
Scholar Rock Holding Corp |
0.62% |
1.97 M |
69.63 M |
| 31 |
CVS
|
CVS Health Corp |
0.60% |
989,715 |
68.27 M |
| 32 |
Avidity Biosciences
|
Avidity Biosciences Inc |
0.58% |
2.30 M |
65.26 M |
| 33 |
SNY
|
Sanofi SA |
0.55% |
1.30 M |
62.63 M |
| 34 |
Blueprint Medicines
|
Blueprint Medicines Corp |
0.53% |
468,745 |
60.08 M |
| 35 |
KYMR
|
Kymera Therapeutics Inc |
0.53% |
1.37 M |
59.61 M |
| 36 |
Akero Therapeutics I
|
Akero Therapeutics Inc |
0.53% |
1.11 M |
59.48 M |
| 37 |
N/A
|
N/A |
0.52% |
21.07 M |
58.74 M |
| 38 |
SMMT
|
Summit Therapeutics Inc |
0.52% |
2.75 M |
58.46 M |
| 39 |
Sonova Holding AG
|
Sonova Holding AG |
0.48% |
182,689 |
54.48 M |
| 40 |
EXAS
|
Exact Sciences Corp |
0.48% |
1.02 M |
54.14 M |
| 41 |
CAH
|
Cardinal Health Inc |
0.47% |
316,322 |
53.14 M |
| 42 |
MLTX
|
MoonLake Immunotherapeutics |
0.46% |
1.10 M |
51.76 M |
| 43 |
Caris Life Sciences
|
Caris Life Sciences Inc |
0.45% |
1.92 M |
51.22 M |
| 44 |
RVMD
|
Revolution Medicines Inc |
0.45% |
1.38 M |
50.61 M |
| 45 |
Soleno Therapeutics
|
Soleno Therapeutics Inc |
0.43% |
586,455 |
49.13 M |
| 46 |
PCVX
|
Vaxcyte Inc |
0.43% |
1.51 M |
49.04 M |
| 47 |
RGEN
|
Repligen Corp |
0.41% |
370,690 |
46.11 M |
| 48 |
BTSG
|
BrightSpring Health Services Inc |
0.39% |
1.86 M |
43.86 M |
| 49 |
VEEV
|
Veeva Systems Inc |
0.38% |
149,336 |
43.01 M |
| 50 |
CNTA
|
Centessa Pharmaceuticals PLC |
0.37% |
3.21 M |
42.15 M |
| 51 |
IDXX
|
IDEXX Laboratories Inc |
0.37% |
77,131 |
41.37 M |
| 52 |
MDGL
|
Madrigal Pharmaceuticals Inc |
0.36% |
135,801 |
41.10 M |
| 53 |
PRCT
|
PROCEPT BioRobotics Corp |
0.36% |
699,487 |
40.29 M |
| 54 |
RVTY
|
Revvity Inc |
0.34% |
401,827 |
38.86 M |
| 55 |
PTGX
|
Protagonist Therapeutics Inc |
0.34% |
685,458 |
37.89 M |
| 56 |
Alkermes PLC
|
Alkermes PLC |
0.32% |
1.25 M |
35.87 M |
| 57 |
DNLI
|
Denali Therapeutics Inc |
0.31% |
2.50 M |
35.00 M |
| 58 |
AGIO
|
Agios Pharmaceuticals Inc |
0.29% |
990,652 |
32.95 M |
| 59 |
CGON
|
CG oncology Inc |
0.28% |
1.20 M |
31.19 M |
| 60 |
CRNX
|
Crinetics Pharmaceuticals Inc |
0.27% |
1.05 M |
30.29 M |
| 61 |
DXCM
|
Dexcom Inc |
0.25% |
322,061 |
28.11 M |
| 62 |
VERA
|
Vera Therapeutics Inc |
0.24% |
1.17 M |
27.56 M |
| 63 |
ACLX
|
Arcellx Inc |
0.24% |
411,543 |
27.10 M |
| 64 |
RARE
|
Ultragenyx Pharmaceutical Inc |
0.23% |
703,570 |
25.58 M |
| 65 |
IMCR
|
Immunocore Holdings PLC |
0.21% |
773,698 |
24.28 M |
| 66 |
Biohaven Ltd
|
Biohaven Ltd |
0.21% |
1.71 M |
24.12 M |
| 67 |
Apogee Therapeutics
|
Apogee Therapeutics Inc |
0.21% |
552,027 |
23.97 M |
| 68 |
Merus NV
|
Merus NV |
0.21% |
444,988 |
23.41 M |
| 69 |
EHC
|
Encompass Health Corp |
0.20% |
187,885 |
23.04 M |
| 70 |
LEGN
|
Legend Biotech Corp |
0.19% |
601,652 |
21.35 M |
| 71 |
RYTM
|
Rhythm Pharmaceuticals Inc |
0.18% |
324,259 |
20.49 M |
| 72 |
IMNM
|
Immunome Inc |
0.18% |
2.19 M |
20.34 M |
| 73 |
IONS
|
Ionis Pharmaceuticals Inc |
0.18% |
512,286 |
20.24 M |
| 74 |
UTHR
|
United Therapeutics Corp |
0.16% |
61,706 |
17.73 M |
| 75 |
REPL
|
Replimune Group Inc |
0.16% |
1.89 M |
17.60 M |
| 76 |
AMGN
|
Amgen Inc |
0.15% |
62,105 |
17.34 M |
| 77 |
Disc Medicine Inc
|
Disc Medicine Inc |
0.14% |
309,390 |
16.39 M |
| 78 |
KRYS
|
Krystal Biotech Inc |
0.14% |
118,808 |
16.33 M |
| 79 |
Praxis Precision Med
|
Praxis Precision Medicines Inc |
0.14% |
374,760 |
15.76 M |
| 80 |
BEAM
|
Beam Therapeutics Inc |
0.14% |
912,997 |
15.53 M |
| 81 |
CLDX
|
Celldex Therapeutics Inc |
0.14% |
750,770 |
15.28 M |
| 82 |
RAPP
|
Rapport Therapeutics Inc |
0.12% |
1.18 M |
13.38 M |
| 83 |
Tenax Therapeutics I
|
Tenax Therapeutics Inc |
0.11% |
3.20 M |
12.40 M |
| 84 |
CYTK
|
Cytokinetics Inc |
0.10% |
337,628 |
11.16 M |
| 85 |
MCK
|
McKesson Corp |
0.10% |
14,842 |
10.88 M |
| 86 |
TARS
|
Tarsus Pharmaceuticals Inc |
0.09% |
263,625 |
10.68 M |
| 87 |
Pharvaris NV
|
Pharvaris NV |
0.09% |
600,613 |
10.57 M |
| 88 |
ORIC
|
ORIC Pharmaceuticals Inc |
0.09% |
1.03 M |
10.44 M |
| 89 |
SYRE
|
Spyre Therapeutics Inc |
0.09% |
690,693 |
10.34 M |
| 90 |
LNTH
|
Lantheus Holdings Inc |
0.09% |
122,002 |
9.99 M |
| 91 |
ICON PLC
|
ICON PLC |
0.08% |
65,434 |
9.52 M |
| 92 |
Helix Acquisition Co
|
Helix Acquisition Corp II |
0.08% |
878,945 |
9.36 M |
| 93 |
JANX
|
Janux Therapeutics Inc |
0.08% |
372,178 |
8.60 M |
| 94 |
OSCR
|
Oscar Health Inc |
0.07% |
383,141 |
8.21 M |
| 95 |
CAI
|
Caris Life Sciences Inc |
0.07% |
285,603 |
7.63 M |
| 96 |
Bicycle Therapeutics
|
Bicycle Therapeutics PLC |
0.07% |
1.09 M |
7.61 M |
| 97 |
WaVe Life Sciences L
|
WaVe Life Sciences Ltd |
0.06% |
1.07 M |
6.98 M |
| 98 |
Crescent Biopharma I
|
Crescent Biopharma Inc |
0.05% |
360,441 |
5.53 M |
| 99 |
Alector Inc
|
Alector Inc |
0.05% |
3.79 M |
5.31 M |
| 100 |
GPCR
|
Structure Therapeutics Inc |
0.05% |
251,171 |
5.21 M |
| 101 |
SANA
|
Sana Biotechnology Inc |
0.04% |
1.74 M |
4.76 M |
| 102 |
XNCR
|
Xencor Inc |
0.04% |
560,805 |
4.41 M |
| 103 |
GLUE
|
Monte Rosa Therapeutics Inc |
0.04% |
947,439 |
4.27 M |
| 104 |
ZLAB
|
Zai Lab Ltd |
0.04% |
122,117 |
4.27 M |
| 105 |
Kyverna Therapeutics
|
Kyverna Therapeutics Inc |
0.04% |
1.38 M |
4.24 M |
| 106 |
Verily Life Sciences
|
Verily Life Sciences LLC |
0.03% |
113,564 |
3.75 M |
| 107 |
Sensorion SA
|
Sensorion SA |
0.03% |
10.03 M |
3.69 M |
| 108 |
IDYA
|
Ideaya Biosciences Inc |
0.03% |
171,812 |
3.61 M |
| 109 |
Exact Sciences Corp
|
Exact Sciences Corp |
0.03% |
5.59 M |
3.47 M |
| 110 |
ALLO
|
Allogene Therapeutics Inc |
0.03% |
2.75 M |
3.11 M |
| 111 |
Cabaletta Bio Inc
|
Cabaletta Bio Inc |
0.03% |
1.94 M |
2.96 M |
| 112 |
ORKA
|
Oruka Therapeutics Inc |
0.03% |
257,030 |
2.88 M |
| 113 |
PAX Labs Inc
|
PAX Labs Inc |
0.02% |
8.40 M |
2.60 M |
| 114 |
Aura Biosciences Inc
|
Aura Biosciences Inc |
0.02% |
327,622 |
2.05 M |
| 115 |
RLAY
|
Relay Therapeutics Inc |
0.02% |
569,278 |
1.97 M |
| 116 |
Lyell Immunopharma I
|
Lyell Immunopharma Inc |
0.02% |
214,565 |
1.90 M |
| 117 |
Cargo Therapeutics I
|
Cargo Therapeutics Inc |
0.02% |
426,331 |
1.76 M |
| 118 |
Rocket Pharmaceutica
|
Rocket Pharmaceuticals Inc |
0.01% |
688,253 |
1.69 M |
| 119 |
TRDA
|
Entrada Therapeutics Inc |
0.01% |
219,570 |
1.48 M |
| 120 |
IOVA
|
Iovance Biotherapeutics Inc |
0.01% |
737,385 |
1.27 M |
| 121 |
Voyager Therapeutics
|
Voyager Therapeutics Inc |
0.01% |
350,448 |
1.09 M |
| 122 |
ARVN
|
Arvinas Inc |
0.01% |
135,859 |
999,922.24 |
| 123 |
Orchestra BioMed Hol
|
Orchestra BioMed Holdings Inc |
0.01% |
290,668 |
778,990.24 |
| 124 |
ANNX
|
Annexon Inc |
0.01% |
258,836 |
621,206.4 |
| 125 |
Prelude Therapeutics
|
Prelude Therapeutics Inc |
0.00% |
661,222 |
535,193.09 |
| 126 |
Generation Bio Co
|
Generation Bio Co |
0.00% |
1.43 M |
457,279.18 |
| 127 |
Ginkgo Bioworks Hold
|
Ginkgo Bioworks Holdings Inc |
0.00% |
28,555 |
321,243.75 |
| 128 |
Revolution Medicines
|
Revolution Medicines Inc |
0.00% |
198,505 |
53,596.35 |
| 129 |
GeneDx Holdings Corp
|
GeneDx Holdings Corp |
0.00% |
206,747 |
13,645.3 |
| 130 |
SomaLogic Inc
|
SomaLogic Inc |
0.00% |
90,179 |
1,037.06 |
| 131 |
Gyroscope Therapeuti
|
Gyroscope Therapeutics Ltd |
0.00% |
13.26 M |
0.0 |
Showing top 10 of 131 holdings
·
Listed: 91.23%
·
8.77% in other positions
{"event":"ticker_viewed","properties":{"ticker":"THISX","listing_kind":"etf","pathname":"/etfs/thisx","exchange":"UNKNOWN"}}